Active targeting strategies for anticancer drug nanocarriers

Area of Science:

• Oncology
• Nanotechnology
• Drug Delivery

Background:

• Chemotherapy is a primary cancer treatment but lacks tumor selectivity, leading to side effects.
• Developing targeted therapies is crucial to enhance efficacy and minimize toxicity.
• Nanoparticle-based drug delivery offers a promising strategy for selective cancer treatment.

Purpose of the Study:

• To review nanoparticle-based active targeting strategies for cancer treatment.
• To highlight opportunities and challenges in current targeted drug delivery approaches.
• To emphasize the need for efficient and long-circulating nanocarriers.

Main Methods:

• Review of literature on liposomes, lipid nanoparticles, polymer nanoparticles, and micelles for active targeting.
• Analysis of strategies for enhancing drug targeting in cancer therapy.
• Discussion of factors influencing nanocarrier performance in vivo.

Main Results:

• Liposomes, lipid nanoparticles, and micelles are key nanoparticle types for active cancer targeting.
• Active targeting strategies show potential for improved therapeutic efficacy and reduced toxicity.
• Challenges include optimizing targeting efficiency and ensuring sufficient bloodstream longevity.

Conclusions:

• Nanoparticle-based active targeting represents a significant advancement in cancer therapy.
• Balancing targeting specificity with prolonged circulation time is essential for clinical success.
• Further research is needed to overcome existing challenges in nanocarrier design and application.